• German
  • English
  • Spanish

NEWS - HAPA pharm

HAPA pharm receives GMP certification

HAPA pharm (“HAPA” or the “Company”) operates production facilities in North Macedonia to grow and process medical cannabis for the sale of pharmaceutical cannabis flos and extracts. On May 1st 2020, the Company has successfully received GMP (Good Manufacturing Practice)

Continue reading »
CME - Continued Medical Education - Cannabis - comings soon - HAPA medical

HAPA Medical becomes HAPA pharm

HAPA pharm is an internationally active company focusing on the research, development and marketing of cannabinoid-containing products and drug formulations. The company, which previously operated under the name of HAPA Medical, has established itself as a pharmaceutical producer. With its

Continue reading »

Website Relaunch

Open source information on cannabinoids in health and disease Heureka, our new website is online! Our team has been working hard to optimize user experience, design, internationality and content. Let us know what you think! And thank you for your

Continue reading »

Pressrelease November 2018

Käfer Dachgarten-Restaurant im Deutschen Bundestag Demnächst steht in Deutschland mit dem HAPA medical Vollspektrum Cannabis Extrakt THC2.5 CBD2.5 (Lösung) ein neues Extrakt zur Herstellung eines Rezepturarzneimittels aus medizinischem Cannabis zur Verfügung. Daher laden wir Journalisten der medizinischen Fachpresse herzlich zur

Continue reading »
Wir lieben Innovation - Cannabis Medizin - HAPA medical

We grow innovation

HAPA medical partners with Australian Zelda Therapeutics for the advancement of clinical cannabinoid research While experimental studies have already unveiled many mechanisms of action for a wide array of cannabinoids, there is still a lack of proper clinical trials which

Continue reading »

Cannabis Becomes Medicine

HAPA pharm is an international company focused on the research, development and distribution of cannabinoid-containing drug formulations. We stand for a controlled cultivation of cannabis plants in the EU as well as for the own production of prescription medicines according to EU-GMP-guidelines.

Newsletter

© All rights reserved

HWG Disclaimer​

The therapeutic potential of cannabis is still largely unexplored. We have to point out that for cannabinoid therapy, reliable evidence of efficacy based on large randomized controlled clinical trials is available for only a few indications. Off-label and no-label prescriptions are therefore common. Therefore, the information presented on our website should not be misunderstood as a promise of healing or as a suggestion to try therapy with cannabis, but is merely for your information to stimulate medical and scientific discourse. We hope to provide you with a serious introduction to the complex topic of cannabinoid therapy on the basis of scientifically sound sources, but do not claim our info to be complete and recommend a deeper self-study of the topic to interested experts. If you notice errors on our pages, we thank you in advance for letting us know. If the medical terms or other content provided here cause you any difficulties in understanding, please ask your doctor or contact us.